Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check7 days agoChange DetectedA new revision (v3.6.0) appears in the history, and the recruitment status is updated to indicate enrollment is closed, replacing the prior revision (v3.5.5).SummaryDifference0.2%

- Check14 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5, signaling a new version of the study record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedNo textual additions or deletions are documented for this record.SummaryDifference0.1%

- Check36 days agoChange DetectedA new site revision entry Revision: v3.5.4 was added to the history, replacing the prior v3.5.3. This reflects a general site update rather than a modification to study content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history. The previous revision v3.5.2 has been removed from the history, reflecting an update to the metadata of the study record.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.